IJand y-catenin are components of catenin family involved in cadherin adhesion function. Recently it has been shown that this family is involved in other functions such as signaling and activation of transcription factors. The final goal of this study was to evaluate the role of IJand y-catenin in bone cell physiology and bone regeneration.
Formalin-fixed-paraffin embedded specimens of 15 human bone specimens after sinus lift were collected and examined by immunohistochemstry using primary antibodies against IJand y-catenin. Staining intensity and cellular localization were evaluated. IJ and y-catenin showed a very high level of expression in human bone tissues. In particular catenins were expressed in cells with morphological findings of osteoblasts in the areas of new bone formation at the junction between mineralized and unmineralized tissue, between osteoid matrix and bone. Osteoclasts showed also positivity for catenins. Osteocytes, cells located in lacunae of mature mineralized bone with function of bone vitality maintenance, showed no expression for catenins. Specimens characterized by high amount of catenins in osteoblasts at 1 0 month showed high grade of bone maturation at 3 0 month. Data demonstrated an overall involvement of catenins in human bone tissues and in particular during bone regeneration process. The presence of staining for IJand y-catenin particularly in osteoblasts demonstrates a significant role of catenins in functions, other than in cadherin interaction, such as signaling and activation of transcription factors during differentiation of bone tissues. Intercellular adhesiveness is mediated by a family of glyco-proteins named cadherins (1), which are composed of an extra-cellular domain, involved in Ca++-dependent homophilic binding to adjacent cells, a trans-membrane domain, and an intra-cellular domain which binds to proteins called catenins (2) . Binding of cadherins to acatenin, a protein homologous to vinculin which binds to actin, and, hence, the formation of the zonula adherens, is mediated by~or y-catenin, which act as adaptators between cadherins and n-catenin. Therefore, these catenins playa crucial role in cadherin function and were recently shown to be involved in other functions such as signaling and activation of transcription factors and cell motility (3) . Moreover, in the Wnt/~-catenin pathway the stabilization and reduced degradation of~-catenin lead to control expression of genes that regulate a diverse array of biological processes. Wnt are cysteine-rich secreted glycoproteins, identified in organisms ranging from hydra to humans (4), that through the interaction with their ligands can activate several different receptor-mediated signal transduction pathways, highly conserved across species, involved in embryonic development, tissue induction, and axial polarity (5) .
E-cadherin, Cadherin-ll and N-cadherin are expressed in osteoblasts and cadherin-mediated adhesion is thought to be essential for human osteoblastic differentiation (6) . The possible role of the cadherinlcatenin complex in bone tissues has been suggested by some studies on bone tumors. Recently catenins have been identified in bone and mutations of the~-catenin gene have been detected in malignant tumors of bone including osteosarcoma (7) . Since, Wnt pathway has been found to playa central role in controlling embryonic bone development and bone mass (8) , and, in many aspects, fractures heal by recapitulating the stages of embryonic bone development it has been proposed that WntJ~-catenin signaling pathway also plays a crucial role in bone regenerative process (9) .
Thus, the aim of this study is to investigate~-and 't: catenin expression in bone processes, in particular in cell proliferation and differentiation during regeneration.
MATERIALS AND METHODS

Patients selection
Fifteen patients requiring sinus elevation procedures with a two-step technique for implants placement were selected. General exclusion criteria from the study were: uncontrolled diabetes, all the immunosuppressive conditions and systemic diseases that may prevent the intervention. Further exclusions were: chemotherapy and radiation therapy to the head and neck region, during the previous 12 months, sepsis and severe general debilitation. On the local level, the following exclusion criteria were applied: active sinusitis or a history of persistent sinus infections, the presence of maxillary cyst, tumors or the displacement of dental roots, the presence of sinus septa, and active periodontal disease. Complete examinations of soft and hard oral tissue were performed on all patients. In all cases, the site analysis was performed with orthopantomography, intraoral radiograms and axial computerized tomography (dentascan).
After an initial preparation, the sinus elevation procedures were performed. In all cases, autologous bone, harvested from omolateral maxillary tuber or from the chin, was used as grafting material. All surgical operations were performed under local anesthesia. One month after the sinus augmentation procedures, the first sampling took place and all patients had bone specimens harvested by trephine drill in the elevated area. Dental implants were positioned three months after sinus grafts and, at this time, a second bone sample was taken. Immunohistochemistry 15 formalin-fixed paraffin-embedded specimens were examined by immunohistochemstry using an avidin-biotin peroxidase technique. Bone bone carrots were placed in 4% paraformaldehyde + 0.1% gluteraldehyde buffered with 0.1 m sodium phosphate, ph 7.2, and fixed for 24 hours at 4C. Then washed in 0.1 M phosphate buffer and decalcified for 6 hours at 4C in Plank-Richlols solution (12.67 g. AICI3, 8.5 ml of IONHCland 5.4 ml of88% formic acid adjusted to 100 ml with distilled water). The decalcified specimens were washed in PBS buffer, dehydrated in ethanol and embedded in paraffin.
Serial 4-micron thick sections were obtained. After antigen retrieval, endogenous peroxidase was inhibited with 3% hydrogen peroxide, and non-specific binding sites were blocked with normal goat serum.
Primary anti~-catenin (lgG1, C19220, Transduction Laboratories, Lexington, KY 40511-2600) generated from mouse~-catenin, used at dilution of 1:700, or primary anti y-catenin (IgGl, Transduction Laboratories, Lexington, KY 40511-2600) at diluition of 1:700, were applied directly to the section and incubated overnight (4°C). The sections were washed three times with PBS. Immune complexes were subsequently treated with the secondary antibody and then detected by means of Streptavidin alkaline phosphatase, both incubated for 30 minutes at room temperature (VectastainABC kit, Vector Laboratories, Burlingame Calif., USA). overnight at 4°C. Sequential 20-minutes incubation with biotinylated linking antibody and peroxidase-labelled streptavidin (L.U:
Dako LSAB + kit, HRP) were performed at room temperature.
The peroxidase activity was developed by incubation with 3.3' -diaminobenzidine (Vector Blue, Vector Laboratories, Burlingame Calif., USA) as a substrate chromogen solution.
Sections were not counterstained with the aim to better evidence the nuclear staining for~-or y-catenin. Positive (normal oral epithelium) and negative (by substituting primary antibody with normal goat serum) controls were performed in each case.
Evaluation
The number of~-and y-catenin expressing cells was evaluated as a percentage of the final number of 300 cells of each case, and scored in two categories: + <50%, ++ >50% independently of the topographical staining pattern (membranous, cytoplasmatic or nuclear).
RESULTS.
Interestingly~-and y-catenin showed a very high level of expression in human bone tissues (Table I, Fig. I ).~ and y-catenin were expressed in cells with morphological findings of osteoblasts in the areas of new bone formation at the junction between mineralized and unmineralised tissue, between osteoid matrix and bone. Osteoblasts showed a membranous/cytoplasmic positivity. Some pre-osteoblasts and young osteoblasts showed a nuclear positivity.
Osteoclasts, identified as large multinucleated cells derived from monocytes with abundant acidophilic cytoplasm, showed also membranous/cytoplasmic positivity.
Osteocytes, cells located in lacunae of mature mineralized bone and involved in maintenance of bone vitality, showed no/low positivity for the two investigated Comparing data of the two samples for each patient, cases characterized by high level of catenins expression in osteoblasts at I°month showed high grade of bone maturation at 3°month (Table II) . At I°month 6 cases showed low catenin expression (+) and 9 moderate/ high expression (++), at 3°month 8 cases showed low expression (+) and 7 no expression. Dividing the cases in two groups, A ,with low expression (6 cases), and B, with high expression of catenin (9 cases), group A showed catenin positivity in 4/6 cases (66%) at 3°month and low grade of bone maturation at histological exam, while group B showed catenin positivity in 4/9 cases (33%) at 3°m onth and lower grade of bone maturation at histological exam than the 5/9 cases negative at this control.
DISCUSSION
Direct cell-cell interactions are fundamental for tissue development and differentiation and cadherin-mediated cell-to-cell adhesion is critical for normal human osteoblast differentiation (9) (10) (11) (12) .
Our data showed positivity for p-and y-catenin in osteoblasts and osteoclasts, while osteocytes were negative. Some osteoblasts showed membranous/ cytoplasmic/nuclear positivity. Probably the different cellular localization of catenins is due and/or induces different functions. Specimens characterized by high level of catenins expression in osteoblasts at 1°month showed high grade of bone maturation at 3°month. As expected, these cases showed also reduced or absent catenin expression at 3°month. It is probably due to the fact that in mature bone osteoblasts become surrounded by matrix and mature in osteocytes. Moreover, it is interesting to notice that catenins expression in early stage of bone forming process was required for bone maturation, suggesting some regulatory function in bone physiology. Indeed, the findings ofthe present investigation confirmed those of previous experimental paper in cells and animal model. N-cadherin-mediated cell-cell adhesion promotes osteoblast survival and this mechanism involves activation of p-catenin signaling (11) . Indeed, in osteoblasts undergoing apoptosis, proteolytic cleavage ofN-cadherin and p-and y-catenins but not n-catenin is associated with the activation ofcaspase-3 (11) .
The nuclear localization of catenins in pre-osteoblasts and some young osteoblasts probably show a regulatory activity for p-and y-catenin. In fact p-catenin in nucleus form a transcriptional complex with TCF/LEF-l and promotes transcription of several genes. Indeed, Wnt pathway is very likely involved during bone regeneration as it represents a mechanism in mesenchymal cells proliferation and differentiation during osteogenesis promoting proliferation and suppressing osteogenic differentiation of adult MSCs (12) . Since a recent study suggested the presence of regulatory interactions between the Wnt and BMP signaling pathways in cancer pathogenesis, suggesting a direct role of nuclear p-catenin in BMP-4 gene transcription and consequently in osteoblast differentiation, a crucial role of p-catenin signaling pathway in BMP-2-induced endochondral ossification was than uncovered (13) (14) (15) (16) Data from previous studied provided lines of evidence that that in early stages of fracture healing, precise regulation of p-catenin is required for pluripotent mesenchymal cells to differentiate to either osteoblasts or chondrocytes. Once these undifferentiated cells have become committed to the osteoblast lineage, pcatenin positively regulates osteoblasts. The data of the present study confirms these view in humans as nuclear expression of p-catenin was detected in pre-osteoblasts and low or no expression was evident in osteocytes. Moreover, cases characterized by high level of catenins expression in osteoblasts at 1 0 month showed high grade of bone maturation at 3 0 month in agreement with an increased bone mass resulted from Wnt co-receptor LRP-5 activation ( 17) .
Furthermore, the nuclear relocation of p-catenin can be due to several factors or events other than Wnt as the receptor for IGF-II (Insulin-like growth factor II), that belongs to the same membrane complex as E-cadherin and -catenin, may induce a redistribution of~-catenin from the plasma membrane to the nucleus and the transcription of~-catenin/TCF-3 target genes (18) .
In conclusion, the immunohistochemical study ofbone after sinus elevation procedure has provided evidence for -catenin and y-catenin expression in humans in vivo bone confirming a pivotal role ofWntJ~-catenin signaling pathwayin bone regeneration and suggesting a previously unrecognized roles for y-catenin proteins in bone cell physiology.
